Global Drugs for Osteoarthritis Pain Market 2019 by Company, Regions, Type and Application, Forecast to 2024
Sep, 2019
|
Report ID: 96351
|
135
|
Pharmaceuticals and Healthcare
Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.
Scope of the Report:
Geographically, the global Drugs for Osteoarthritis Pain
market has been segmented into North America, Europe, China, Japan, Rest of Asia (RoA), and Rest of World (RoW). The North America held the largest share in the global market, its revenue of global market exceeds 38% in 2017. The next is Europe.
The global Drugs for Osteoarthritis Pain market is valued at 7440 million USD in 2018 and is expected to reach 10400 million USD by the end of 2024, growing at a CAGR of 5.8% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Drugs for Osteoarthritis Pain.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Drugs for Osteoarthritis Pain market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Drugs for Osteoarthritis Pain market by product type and applications/end industries.
Market Segment by Companies, this report covers
Pfizer
Johnson & Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oral
Injection
External
Market Segment by Applications, can be divided into
Medical Care
Personal Care
Scope of the Report:
Geographically, the global Drugs for Osteoarthritis Pain
market has been segmented into North America, Europe, China, Japan, Rest of Asia (RoA), and Rest of World (RoW). The North America held the largest share in the global market, its revenue of global market exceeds 38% in 2017. The next is Europe.
The global Drugs for Osteoarthritis Pain market is valued at 7440 million USD in 2018 and is expected to reach 10400 million USD by the end of 2024, growing at a CAGR of 5.8% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Drugs for Osteoarthritis Pain.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Drugs for Osteoarthritis Pain market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Drugs for Osteoarthritis Pain market by product type and applications/end industries.
Market Segment by Companies, this report covers
Pfizer
Johnson & Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oral
Injection
External
Market Segment by Applications, can be divided into
Medical Care
Personal Care
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Drugs for Osteoarthritis Pain Market Overview
1.1 Product Overview and Scope of Drugs for Osteoarthritis Pain
1.2 Classification of Drugs for Osteoarthritis Pain by Types
1.2.1 Global Drugs for Osteoarthritis Pain Revenue Comparison by Types (2019-2024)
1.2.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Types in 2018
1.2.3 Oral
1.2.4 Injection
1.2.5 External
1.3 Global Drugs for Osteoarthritis Pain Market by Application
1.3.1 Global Drugs for Osteoarthritis Pain Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Global Drugs for Osteoarthritis Pain Market by Regions
1.4.1 Global Drugs for Osteoarthritis Pain Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Drugs for Osteoarthritis Pain Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Drugs for Osteoarthritis Pain Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Drugs for Osteoarthritis Pain Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Drugs for Osteoarthritis Pain Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Drugs for Osteoarthritis Pain Status and Prospect (2014-2024)
1.5 Global Market Size of Drugs for Osteoarthritis Pain (2014-2024)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Drugs for Osteoarthritis Pain Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.2 Johnson & Johnson
2.2.1 Business Overview
2.2.2 Drugs for Osteoarthritis Pain Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.3 GlaxoSmithKline
2.3.1 Business Overview
2.3.2 Drugs for Osteoarthritis Pain Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.4 Bayer
2.4.1 Business Overview
2.4.2 Drugs for Osteoarthritis Pain Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bayer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.5 Eli Lilly
2.5.1 Business Overview
2.5.2 Drugs for Osteoarthritis Pain Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Eli Lilly Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.6 Novartis
2.6.1 Business Overview
2.6.2 Drugs for Osteoarthritis Pain Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.7 Sanofi
2.7.1 Business Overview
2.7.2 Drugs for Osteoarthritis Pain Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sanofi Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.8 Horizon Pharma
2.8.1 Business Overview
2.8.2 Drugs for Osteoarthritis Pain Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.9 Abbott
2.9.1 Business Overview
2.9.2 Drugs for Osteoarthritis Pain Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Abbott Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.10 Mylan
2.10.1 Business Overview
2.10.2 Drugs for Osteoarthritis Pain Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Mylan Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.11 Daiichi Sankyo
2.11.1 Business Overview
2.11.2 Drugs for Osteoarthritis Pain Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.12 TEVA
2.12.1 Business Overview
2.12.2 Drugs for Osteoarthritis Pain Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 TEVA Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.13 Almatica Pharma
2.13.1 Business Overview
2.13.2 Drugs for Osteoarthritis Pain Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.14 Astellas Pharma
2.14.1 Business Overview
2.14.2 Drugs for Osteoarthritis Pain Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.15 Tide Pharmaceutical
2.15.1 Business Overview
2.15.2 Drugs for Osteoarthritis Pain Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.16 Iroko Pharmaceuticals
2.16.1 Business Overview
2.16.2 Drugs for Osteoarthritis Pain Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.17 Hengrui Pharmaceutical
2.17.1 Business Overview
2.17.2 Drugs for Osteoarthritis Pain Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.18 Abiogen Pharma
2.18.1 Business Overview
2.18.2 Drugs for Osteoarthritis Pain Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
3 Global Drugs for Osteoarthritis Pain Market Competition, by Players
3.1 Global Drugs for Osteoarthritis Pain Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Drugs for Osteoarthritis Pain Players Market Share
3.2.2 Top 10 Drugs for Osteoarthritis Pain Players Market Share
3.3 Market Competition Trend
4 Global Drugs for Osteoarthritis Pain Market Size by Regions
4.1 Global Drugs for Osteoarthritis Pain Revenue and Market Share by Regions
4.2 North America Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
4.3 Europe Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
4.5 South America Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
5 North America Drugs for Osteoarthritis Pain Revenue by Countries
5.1 North America Drugs for Osteoarthritis Pain Revenue by Countries (2014-2019)
5.2 USA Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
5.3 Canada Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
5.4 Mexico Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
6 Europe Drugs for Osteoarthritis Pain Revenue by Countries
6.1 Europe Drugs for Osteoarthritis Pain Revenue by Countries (2014-2019)
6.2 Germany Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
6.3 UK Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
6.4 France Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
6.5 Russia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
6.6 Italy Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Countries
7.1 Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Countries (2014-2019)
7.2 China Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
7.3 Japan Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
7.4 Korea Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
7.5 India Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
8 South America Drugs for Osteoarthritis Pain Revenue by Countries
8.1 South America Drugs for Osteoarthritis Pain Revenue by Countries (2014-2019)
8.2 Brazil Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
8.3 Argentina Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
8.4 Colombia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Drugs for Osteoarthritis Pain by Countries
9.1 Middle East and Africa Drugs for Osteoarthritis Pain Revenue by Countries (2014-2019)
9.2 Saudi Arabia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
9.3 UAE Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
9.4 Egypt Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
9.5 Nigeria Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
9.6 South Africa Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
10 Global Drugs for Osteoarthritis Pain Market Segment by Type
10.1 Global Drugs for Osteoarthritis Pain Revenue and Market Share by Type (2014-2019)
10.2 Global Drugs for Osteoarthritis Pain Market Forecast by Type (2019-2024)
10.3 Oral Revenue Growth Rate (2014-2024)
10.4 Injection Revenue Growth Rate (2014-2024)
10.5 External Revenue Growth Rate (2014-2024)
11 Global Drugs for Osteoarthritis Pain Market Segment by Application
11.1 Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2014-2019)
11.2 Drugs for Osteoarthritis Pain Market Forecast by Application (2019-2024)
11.3 Medical Care Revenue Growth (2014-2019)
11.4 Personal Care Revenue Growth (2014-2019)
12 Global Drugs for Osteoarthritis Pain Market Size Forecast (2019-2024)
12.1 Global Drugs for Osteoarthritis Pain Market Size Forecast (2019-2024)
12.2 Global Drugs for Osteoarthritis Pain Market Forecast by Regions (2019-2024)
12.3 North America Drugs for Osteoarthritis Pain Revenue Market Forecast (2019-2024)
12.4 Europe Drugs for Osteoarthritis Pain Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Drugs for Osteoarthritis Pain Revenue Market Forecast (2019-2024)
12.6 South America Drugs for Osteoarthritis Pain Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Drugs for Osteoarthritis Pain Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
1 Drugs for Osteoarthritis Pain Market Overview
1.1 Product Overview and Scope of Drugs for Osteoarthritis Pain
1.2 Classification of Drugs for Osteoarthritis Pain by Types
1.2.1 Global Drugs for Osteoarthritis Pain Revenue Comparison by Types (2019-2024)
1.2.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Types in 2018
1.2.3 Oral
1.2.4 Injection
1.2.5 External
1.3 Global Drugs for Osteoarthritis Pain Market by Application
1.3.1 Global Drugs for Osteoarthritis Pain Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Global Drugs for Osteoarthritis Pain Market by Regions
1.4.1 Global Drugs for Osteoarthritis Pain Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Drugs for Osteoarthritis Pain Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Drugs for Osteoarthritis Pain Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Drugs for Osteoarthritis Pain Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Drugs for Osteoarthritis Pain Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Drugs for Osteoarthritis Pain Status and Prospect (2014-2024)
1.5 Global Market Size of Drugs for Osteoarthritis Pain (2014-2024)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Drugs for Osteoarthritis Pain Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.2 Johnson & Johnson
2.2.1 Business Overview
2.2.2 Drugs for Osteoarthritis Pain Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.3 GlaxoSmithKline
2.3.1 Business Overview
2.3.2 Drugs for Osteoarthritis Pain Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.4 Bayer
2.4.1 Business Overview
2.4.2 Drugs for Osteoarthritis Pain Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bayer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.5 Eli Lilly
2.5.1 Business Overview
2.5.2 Drugs for Osteoarthritis Pain Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Eli Lilly Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.6 Novartis
2.6.1 Business Overview
2.6.2 Drugs for Osteoarthritis Pain Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.7 Sanofi
2.7.1 Business Overview
2.7.2 Drugs for Osteoarthritis Pain Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sanofi Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.8 Horizon Pharma
2.8.1 Business Overview
2.8.2 Drugs for Osteoarthritis Pain Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.9 Abbott
2.9.1 Business Overview
2.9.2 Drugs for Osteoarthritis Pain Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Abbott Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.10 Mylan
2.10.1 Business Overview
2.10.2 Drugs for Osteoarthritis Pain Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Mylan Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.11 Daiichi Sankyo
2.11.1 Business Overview
2.11.2 Drugs for Osteoarthritis Pain Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.12 TEVA
2.12.1 Business Overview
2.12.2 Drugs for Osteoarthritis Pain Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 TEVA Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.13 Almatica Pharma
2.13.1 Business Overview
2.13.2 Drugs for Osteoarthritis Pain Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.14 Astellas Pharma
2.14.1 Business Overview
2.14.2 Drugs for Osteoarthritis Pain Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.15 Tide Pharmaceutical
2.15.1 Business Overview
2.15.2 Drugs for Osteoarthritis Pain Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.16 Iroko Pharmaceuticals
2.16.1 Business Overview
2.16.2 Drugs for Osteoarthritis Pain Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.17 Hengrui Pharmaceutical
2.17.1 Business Overview
2.17.2 Drugs for Osteoarthritis Pain Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
2.18 Abiogen Pharma
2.18.1 Business Overview
2.18.2 Drugs for Osteoarthritis Pain Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
3 Global Drugs for Osteoarthritis Pain Market Competition, by Players
3.1 Global Drugs for Osteoarthritis Pain Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Drugs for Osteoarthritis Pain Players Market Share
3.2.2 Top 10 Drugs for Osteoarthritis Pain Players Market Share
3.3 Market Competition Trend
4 Global Drugs for Osteoarthritis Pain Market Size by Regions
4.1 Global Drugs for Osteoarthritis Pain Revenue and Market Share by Regions
4.2 North America Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
4.3 Europe Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
4.5 South America Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
5 North America Drugs for Osteoarthritis Pain Revenue by Countries
5.1 North America Drugs for Osteoarthritis Pain Revenue by Countries (2014-2019)
5.2 USA Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
5.3 Canada Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
5.4 Mexico Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
6 Europe Drugs for Osteoarthritis Pain Revenue by Countries
6.1 Europe Drugs for Osteoarthritis Pain Revenue by Countries (2014-2019)
6.2 Germany Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
6.3 UK Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
6.4 France Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
6.5 Russia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
6.6 Italy Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Countries
7.1 Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Countries (2014-2019)
7.2 China Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
7.3 Japan Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
7.4 Korea Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
7.5 India Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
8 South America Drugs for Osteoarthritis Pain Revenue by Countries
8.1 South America Drugs for Osteoarthritis Pain Revenue by Countries (2014-2019)
8.2 Brazil Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
8.3 Argentina Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
8.4 Colombia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Drugs for Osteoarthritis Pain by Countries
9.1 Middle East and Africa Drugs for Osteoarthritis Pain Revenue by Countries (2014-2019)
9.2 Saudi Arabia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
9.3 UAE Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
9.4 Egypt Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
9.5 Nigeria Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
9.6 South Africa Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
10 Global Drugs for Osteoarthritis Pain Market Segment by Type
10.1 Global Drugs for Osteoarthritis Pain Revenue and Market Share by Type (2014-2019)
10.2 Global Drugs for Osteoarthritis Pain Market Forecast by Type (2019-2024)
10.3 Oral Revenue Growth Rate (2014-2024)
10.4 Injection Revenue Growth Rate (2014-2024)
10.5 External Revenue Growth Rate (2014-2024)
11 Global Drugs for Osteoarthritis Pain Market Segment by Application
11.1 Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2014-2019)
11.2 Drugs for Osteoarthritis Pain Market Forecast by Application (2019-2024)
11.3 Medical Care Revenue Growth (2014-2019)
11.4 Personal Care Revenue Growth (2014-2019)
12 Global Drugs for Osteoarthritis Pain Market Size Forecast (2019-2024)
12.1 Global Drugs for Osteoarthritis Pain Market Size Forecast (2019-2024)
12.2 Global Drugs for Osteoarthritis Pain Market Forecast by Regions (2019-2024)
12.3 North America Drugs for Osteoarthritis Pain Revenue Market Forecast (2019-2024)
12.4 Europe Drugs for Osteoarthritis Pain Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Drugs for Osteoarthritis Pain Revenue Market Forecast (2019-2024)
12.6 South America Drugs for Osteoarthritis Pain Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Drugs for Osteoarthritis Pain Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Drugs for Osteoarthritis Pain Picture
Table Product Specifications of Drugs for Osteoarthritis Pain
Table Global Drugs for Osteoarthritis Pain and Revenue (Million USD) Market Split by Product Type
Figure Global Drugs for Osteoarthritis Pain Revenue Market Share by Types in 2018
Figure Oral Picture
Figure Injection Picture
Figure External Picture
Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) by Application (2014-2024)
Figure Drugs for Osteoarthritis Pain Revenue Market Share by Applications in 2018
Figure Medical Care Picture
Figure Personal Care Picture
Table Global Market Drugs for Osteoarthritis Pain Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Drugs for Osteoarthritis Pain Type and Applications
Table Pfizer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Drugs for Osteoarthritis Pain Type and Applications
Table Johnson & Johnson Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Drugs for Osteoarthritis Pain Type and Applications
Table GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Drugs for Osteoarthritis Pain Type and Applications
Table Bayer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Drugs for Osteoarthritis Pain Type and Applications
Table Eli Lilly Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Drugs for Osteoarthritis Pain Type and Applications
Table Novartis Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Drugs for Osteoarthritis Pain Type and Applications
Table Sanofi Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Horizon Pharma Basic Information, Manufacturing Base and Competitors
Table Horizon Pharma Drugs for Osteoarthritis Pain Type and Applications
Table Horizon Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Drugs for Osteoarthritis Pain Type and Applications
Table Abbott Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Drugs for Osteoarthritis Pain Type and Applications
Table Mylan Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table Daiichi Sankyo Drugs for Osteoarthritis Pain Type and Applications
Table Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table TEVA Basic Information, Manufacturing Base and Competitors
Table TEVA Drugs for Osteoarthritis Pain Type and Applications
Table TEVA Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Almatica Pharma Basic Information, Manufacturing Base and Competitors
Table Almatica Pharma Drugs for Osteoarthritis Pain Type and Applications
Table Almatica Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table Astellas Pharma Drugs for Osteoarthritis Pain Type and Applications
Table Astellas Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Tide Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Tide Pharmaceutical Drugs for Osteoarthritis Pain Type and Applications
Table Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Iroko Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Type and Applications
Table Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Hengrui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Type and Applications
Table Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Abiogen Pharma Basic Information, Manufacturing Base and Competitors
Table Abiogen Pharma Drugs for Osteoarthritis Pain Type and Applications
Table Abiogen Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) by Players (2014-2019)
Table Global Drugs for Osteoarthritis Pain Revenue Share by Players (2014-2019)
Figure Global Drugs for Osteoarthritis Pain Revenue Share by Players in 2017
Figure Global Drugs for Osteoarthritis Pain Revenue Share by Players in 2018
Figure Global Top 5 Players Drugs for Osteoarthritis Pain Revenue Market Share in 2018
Figure Global Top 10 Players Drugs for Osteoarthritis Pain Revenue Market Share in 2018
Figure Global Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) by Regions (2014-2019)
Table Global Drugs for Osteoarthritis Pain Revenue Market Share by Regions (2014-2019)
Figure Global Drugs for Osteoarthritis Pain Revenue Market Share by Regions (2014-2019)
Figure Global Drugs for Osteoarthritis Pain Revenue Market Share by Regions in 2018
Figure North America Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Europe Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure South America Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Table North America Drugs for Osteoarthritis Pain Revenue by Countries (2014-2019)
Table North America Drugs for Osteoarthritis Pain Revenue Market Share by Countries (2014-2019)
Figure North America Drugs for Osteoarthritis Pain Revenue Market Share by Countries (2014-2019)
Figure North America Drugs for Osteoarthritis Pain Revenue Market Share by Countries in 2018
Figure USA Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Canada Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Mexico Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Table Europe Drugs for Osteoarthritis Pain Revenue (Million USD) by Countries (2014-2019)
Figure Europe Drugs for Osteoarthritis Pain Revenue Market Share by Countries (2014-2019)
Figure Europe Drugs for Osteoarthritis Pain Revenue Market Share by Countries in 2018
Figure Germany Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure UK Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure France Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Russia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Italy Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Drugs for Osteoarthritis Pain Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Revenue Market Share by Countries in 2018
Figure China Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Japan Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Korea Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure India Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Table South America Drugs for Osteoarthritis Pain Revenue by Countries (2014-2019)
Table South America Drugs for Osteoarthritis Pain Revenue Market Share by Countries (2014-2019)
Figure South America Drugs for Osteoarthritis Pain Revenue Market Share by Countries (2014-2019)
Figure South America Drugs for Osteoarthritis Pain Revenue Market Share by Countries in 2018
Figure Brazil Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Argentina Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Colombia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Drugs for Osteoarthritis Pain Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Drugs for Osteoarthritis Pain Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Drugs for Osteoarthritis Pain Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Drugs for Osteoarthritis Pain Revenue Market Share by Countries in 2018
Figure Saudi Arabia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure UAE Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Egypt Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Nigeria Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure South Africa Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) by Type (2014-2019)
Table Global Drugs for Osteoarthritis Pain Revenue Share by Type (2014-2019)
Figure Global Drugs for Osteoarthritis Pain Revenue Share by Type (2014-2019)
Figure Global Drugs for Osteoarthritis Pain Revenue Share by Type in 2019
Table Global Drugs for Osteoarthritis Pain Revenue Forecast by Type (2019-2024)
Figure Global Drugs for Osteoarthritis Pain Market Share Forecast by Type (2019-2024)
Figure Global Oral Revenue Growth Rate (2014-2019)
Figure Global Injection Revenue Growth Rate (2014-2019)
Figure Global External Revenue Growth Rate (2014-2019)
Table Global Drugs for Osteoarthritis Pain Revenue by Application (2014-2019)
Table Global Drugs for Osteoarthritis Pain Revenue Share by Application (2014-2019)
Figure Global Drugs for Osteoarthritis Pain Revenue Share by Application (2014-2019)
Figure Global Drugs for Osteoarthritis Pain Revenue Share by Application in 2019
Table Global Drugs for Osteoarthritis Pain Revenue Forecast by Application (2019-2024)
Figure Global Drugs for Osteoarthritis Pain Market Share Forecast by Application (2019-2024)
Figure Global Medical Care Revenue Growth Rate (2014-2019)
Figure Global Personal Care Revenue Growth Rate (2014-2019)
Figure Global Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Drugs for Osteoarthritis Pain Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Drugs for Osteoarthritis Pain Revenue Market Forecast (2019-2024)
Figure Europe Drugs for Osteoarthritis Pain Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Revenue Market Forecast (2019-2024)
Figure South America Drugs for Osteoarthritis Pain Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Drugs for Osteoarthritis Pain Revenue Market Forecast (2019-2024)
Figure Drugs for Osteoarthritis Pain Picture
Table Product Specifications of Drugs for Osteoarthritis Pain
Table Global Drugs for Osteoarthritis Pain and Revenue (Million USD) Market Split by Product Type
Figure Global Drugs for Osteoarthritis Pain Revenue Market Share by Types in 2018
Figure Oral Picture
Figure Injection Picture
Figure External Picture
Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) by Application (2014-2024)
Figure Drugs for Osteoarthritis Pain Revenue Market Share by Applications in 2018
Figure Medical Care Picture
Figure Personal Care Picture
Table Global Market Drugs for Osteoarthritis Pain Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Drugs for Osteoarthritis Pain Type and Applications
Table Pfizer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Drugs for Osteoarthritis Pain Type and Applications
Table Johnson & Johnson Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Drugs for Osteoarthritis Pain Type and Applications
Table GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Drugs for Osteoarthritis Pain Type and Applications
Table Bayer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Drugs for Osteoarthritis Pain Type and Applications
Table Eli Lilly Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Drugs for Osteoarthritis Pain Type and Applications
Table Novartis Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Drugs for Osteoarthritis Pain Type and Applications
Table Sanofi Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Horizon Pharma Basic Information, Manufacturing Base and Competitors
Table Horizon Pharma Drugs for Osteoarthritis Pain Type and Applications
Table Horizon Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Drugs for Osteoarthritis Pain Type and Applications
Table Abbott Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Drugs for Osteoarthritis Pain Type and Applications
Table Mylan Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table Daiichi Sankyo Drugs for Osteoarthritis Pain Type and Applications
Table Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table TEVA Basic Information, Manufacturing Base and Competitors
Table TEVA Drugs for Osteoarthritis Pain Type and Applications
Table TEVA Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Almatica Pharma Basic Information, Manufacturing Base and Competitors
Table Almatica Pharma Drugs for Osteoarthritis Pain Type and Applications
Table Almatica Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table Astellas Pharma Drugs for Osteoarthritis Pain Type and Applications
Table Astellas Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Tide Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Tide Pharmaceutical Drugs for Osteoarthritis Pain Type and Applications
Table Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Iroko Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Type and Applications
Table Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Hengrui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Type and Applications
Table Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Abiogen Pharma Basic Information, Manufacturing Base and Competitors
Table Abiogen Pharma Drugs for Osteoarthritis Pain Type and Applications
Table Abiogen Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2017-2018)
Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) by Players (2014-2019)
Table Global Drugs for Osteoarthritis Pain Revenue Share by Players (2014-2019)
Figure Global Drugs for Osteoarthritis Pain Revenue Share by Players in 2017
Figure Global Drugs for Osteoarthritis Pain Revenue Share by Players in 2018
Figure Global Top 5 Players Drugs for Osteoarthritis Pain Revenue Market Share in 2018
Figure Global Top 10 Players Drugs for Osteoarthritis Pain Revenue Market Share in 2018
Figure Global Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) by Regions (2014-2019)
Table Global Drugs for Osteoarthritis Pain Revenue Market Share by Regions (2014-2019)
Figure Global Drugs for Osteoarthritis Pain Revenue Market Share by Regions (2014-2019)
Figure Global Drugs for Osteoarthritis Pain Revenue Market Share by Regions in 2018
Figure North America Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Europe Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure South America Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Table North America Drugs for Osteoarthritis Pain Revenue by Countries (2014-2019)
Table North America Drugs for Osteoarthritis Pain Revenue Market Share by Countries (2014-2019)
Figure North America Drugs for Osteoarthritis Pain Revenue Market Share by Countries (2014-2019)
Figure North America Drugs for Osteoarthritis Pain Revenue Market Share by Countries in 2018
Figure USA Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Canada Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Mexico Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Table Europe Drugs for Osteoarthritis Pain Revenue (Million USD) by Countries (2014-2019)
Figure Europe Drugs for Osteoarthritis Pain Revenue Market Share by Countries (2014-2019)
Figure Europe Drugs for Osteoarthritis Pain Revenue Market Share by Countries in 2018
Figure Germany Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure UK Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure France Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Russia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Italy Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Drugs for Osteoarthritis Pain Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Revenue Market Share by Countries in 2018
Figure China Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Japan Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Korea Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure India Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Table South America Drugs for Osteoarthritis Pain Revenue by Countries (2014-2019)
Table South America Drugs for Osteoarthritis Pain Revenue Market Share by Countries (2014-2019)
Figure South America Drugs for Osteoarthritis Pain Revenue Market Share by Countries (2014-2019)
Figure South America Drugs for Osteoarthritis Pain Revenue Market Share by Countries in 2018
Figure Brazil Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Argentina Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Colombia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Drugs for Osteoarthritis Pain Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Drugs for Osteoarthritis Pain Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Drugs for Osteoarthritis Pain Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Drugs for Osteoarthritis Pain Revenue Market Share by Countries in 2018
Figure Saudi Arabia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure UAE Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Egypt Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure Nigeria Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Figure South Africa Drugs for Osteoarthritis Pain Revenue and Growth Rate (2014-2019)
Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) by Type (2014-2019)
Table Global Drugs for Osteoarthritis Pain Revenue Share by Type (2014-2019)
Figure Global Drugs for Osteoarthritis Pain Revenue Share by Type (2014-2019)
Figure Global Drugs for Osteoarthritis Pain Revenue Share by Type in 2019
Table Global Drugs for Osteoarthritis Pain Revenue Forecast by Type (2019-2024)
Figure Global Drugs for Osteoarthritis Pain Market Share Forecast by Type (2019-2024)
Figure Global Oral Revenue Growth Rate (2014-2019)
Figure Global Injection Revenue Growth Rate (2014-2019)
Figure Global External Revenue Growth Rate (2014-2019)
Table Global Drugs for Osteoarthritis Pain Revenue by Application (2014-2019)
Table Global Drugs for Osteoarthritis Pain Revenue Share by Application (2014-2019)
Figure Global Drugs for Osteoarthritis Pain Revenue Share by Application (2014-2019)
Figure Global Drugs for Osteoarthritis Pain Revenue Share by Application in 2019
Table Global Drugs for Osteoarthritis Pain Revenue Forecast by Application (2019-2024)
Figure Global Drugs for Osteoarthritis Pain Market Share Forecast by Application (2019-2024)
Figure Global Medical Care Revenue Growth Rate (2014-2019)
Figure Global Personal Care Revenue Growth Rate (2014-2019)
Figure Global Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Drugs for Osteoarthritis Pain Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Drugs for Osteoarthritis Pain Revenue Market Forecast (2019-2024)
Figure Europe Drugs for Osteoarthritis Pain Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Drugs for Osteoarthritis Pain Revenue Market Forecast (2019-2024)
Figure South America Drugs for Osteoarthritis Pain Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Drugs for Osteoarthritis Pain Revenue Market Forecast (2019-2024)
